Novo on US senate subpoena vote: "We have repeatedly told them that Lars Fruergaard would be happy to testify"
Novo Nordisk is surprised that Senate Health Committee Chairman Bernie Sanders has announced a vote to subpoena Doug Langa, Novo Nordisk’s executive vice president responsible for the US market.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.